The high failure rates associated with pharmaceutical development are referred to as “attrition rates,” requiring decisions to be made early in the development of a drug to quickly “kill” projects to avoid costly failures.
Viwango vya juu vya kufeli vinavyohusiana na maendeleo ya dawa hujulikana kama &quot;kiwango cha kutoa&quot;, vinavyohitaji maamuzi wakati wa hatua za mwanzo za maendeleo ya dawa ili &quot;kuua&quot; miradi mapema kuepuka kufeli ya gharama kubwa.